Resources from the same session
822O - Activation of γ9δ2 T cells by ICT01 as a novel immunotherapeutic approach for relapsed/refractory hematologic cancers (EVICTION trial)
Presenter: Sylvain Garciaz
Session: Proffered paper session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
823O - Preliminary pharmacokinetics (PK) and pharmacodynamic (PD) analysis of the CD123 NK cell engager (NKCE) SAR443579 in patients (pts) with relapsed or refractory acute myeloid leukemia (R/R AML), B cell acute lymphoblastic leukemia (B-ALL) or high risk-myelodysplasia (HR-MDS)
Presenter: Mojca Jongen-Lavrencic
Session: Proffered paper session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
Invited Discussant 822O and 823O
Presenter: Davide Rossi
Session: Proffered paper session - Haematological malignancies
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered paper session - Haematological malignancies
Resources:
Webcast
824O - Treatment and survival in patients with localized primary ocular adnexal MALT lymphoma: A large bicentric cohort study
Presenter: Lin-rui Gao
Session: Proffered paper session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
825O - Genomic traits of therapeutic response to anti-PD-1 therapy in peripheral T cell lymphoma
Presenter: Ning Lou
Session: Proffered paper session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
826O - A single-arm, multicenter clinical study of radiotherapy combined with toripalimab in stage I/II extranodal NK/T cell lymphoma
Presenter: Ming Jiang
Session: Proffered paper session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
Invited Discussant 824O, 825O and 824O
Presenter: Olivier Casasnovas
Session: Proffered paper session - Haematological malignancies
Resources:
Slides
Webcast